LINC02802

Across TCGA pan-cancer cohorts, LINC02802 RNA differs between tumor and matched normal tissue in 18 of 18 cancer types tested, making tumor–normal expression one of LINC02802’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02802 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02802 is over-expressed in tumor, although a few such as UCEC and BRCA show the opposite, repressed pattern.

KIRC, HNSC, and KIRP are the cancer types where LINC02802 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02802 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	IV	+1.555	<.001	11	view →
HNSC	All	III,IV	+0.854	<.001	11	view →
KIRP	Female	All	+1.531	<.001	9	view →
LIHC	Female	All	+0.324	<.001	7	view →
UCEC	All	All	−0.805	<.001	6	view →
BRCA	All	III,IV	−0.690	<.001	6	view →
LUAD	All	All	+0.446	<.001	6	view →
THCA	All	All	−0.220	<.001	6	view →
BLCA	All	IV	−0.801	<.001	5	view →
LUSC	Male	All	+0.520	<.001	5	view →
KICH	Female	II,III,IV	−1.018	<.001	4	view →
CHOL	Male	All	+1.055	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 18 lineages.

LINC02802–KIRC

Open the KIRC breakdown →